Efficacy and Tolerability of Escitalopram in Treatment of Major Depressive Disorder With Anxiety Symptoms: A 24-Week, Open-Label, Prospective Study in Chinese Population
Neuropsychiatric Disease and Treatment
doi 10.2147/ndt.s120190
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2017
Authors
Publisher
Informa UK Limited